BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21299006)

  • 1. Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.
    Hrycushko BA; Gutierrez AN; Goins B; Yan W; Phillips WT; Otto PM; Bao A
    Phys Med Biol; 2011 Feb; 56(3):703-19. PubMed ID: 21299006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.
    Hrycushko BA; Li S; Goins B; Otto RA; Bao A
    Med Phys; 2011 Mar; 38(3):1339-47. PubMed ID: 21520844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes.
    Hrycushko BA; Li S; Shi C; Goins B; Liu Y; Phillips WT; Otto PM; Bao A
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):948-55. PubMed ID: 20864271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.
    Hrycushko BA; Ware S; Li S; Bao A
    Phys Med Biol; 2011 Sep; 56(17):5721-34. PubMed ID: 21841210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.
    Phillips WT; Goins B; Bao A; Vargas D; Guttierez JE; Trevino A; Miller JR; Henry J; Zuniga R; Vecil G; Brenner AJ
    Neuro Oncol; 2012 Apr; 14(4):416-25. PubMed ID: 22427110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining the LKB NTCP model with radiosensitivity parameters to characterize toxicity of radionuclides based on a multiclonogen kidney model: a theoretical assessment.
    Lin H; Jing J; Xu L; Wu D; Xu Y
    Australas Phys Eng Sci Med; 2012 Jun; 35(2):165-76. PubMed ID: 22678954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
    Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
    Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.
    French JT; Goins B; Saenz M; Li S; Garcia-Rojas X; Phillips WT; Otto RA; Bao A
    J Vasc Interv Radiol; 2010 Aug; 21(8):1271-9. PubMed ID: 20478719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft.
    Li S; Goins B; Phillips WT; Saenz M; Otto PM; Bao A
    Breast Cancer Res Treat; 2011 Nov; 130(1):97-107. PubMed ID: 21181436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical Note: Dosimetric impact of spherical applicator size in Intrabeam™ IORT for treating unicentric breast cancer lesions.
    Saleh Y; Zhang H
    Med Phys; 2017 Dec; 44(12):6706-6714. PubMed ID: 29072347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes.
    Li S; Goins B; Hrycushko BA; Phillips WT; Bao A
    Mol Pharm; 2012 Sep; 9(9):2513-22. PubMed ID: 22894603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer.
    Zhang Y; Huang Y; Ding S; Yuan X; Shu Y; Liang J; Mao Q; Jiang C; Li J
    Radiat Oncol; 2021 Sep; 16(1):171. PubMed ID: 34488817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
    Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric analysis of breast cancer tumor bed boost: An interstitial brachytherapy vs. external beam radiation therapy comparison for deeply seated tumors.
    Shahbazian H; Bakhshali R; Shamsi A; Bagheri A
    Brachytherapy; 2020; 19(2):264-274. PubMed ID: 31787575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
    Werner M; Scheinert D; Henn M; Scheinert S; Bräunlich S; Bausback Y; Friedenberger J; Schuster J; Hertting K; Piorkowski M; Rosner C; Schmidt A; Ulrich M; Gutberlet M
    J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
    Zhang H; Donnelly ED; Strauss JB; Qi Y
    Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.